$CERS
CERUS CORP Stock $cers

$cers Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000119312515283091 Filed on August 07, 2015

Income Statement

Concept	2015 Q2	2014 Q4	2014 Q2
Revenue	$8.830M	$9.587M	$8.601M
YoY Change	2.66%	3.85%	-15.26%
Cost Of Revenue	$7.028M	$6.590M	$4.752M
YoY Change	47.9%	33.43%	-17.31%
Gross Profit	$1.802M	$2.997M	$3.849M
YoY Change	-53.18%	-30.19%	-12.58%
Gross Profit Margin	20.41%	31.26%	44.75%
Selling, General & Admin	$12.06M	$10.69M	$10.08M
YoY Change	19.67%	43.88%	26.73%
% of Gross Profit	669.42%	356.69%	261.89%
Research & Development	$5.213M	$5.190M	$4.722M
YoY Change	10.4%	12.39%	34.68%
% of Gross Profit	289.29%	173.17%	122.68%
Depreciation & Amortization	$400.0K	$430.0K	$290.0K
YoY Change	37.93%	26.47%	163.64%
% of Gross Profit	22.2%	14.35%	7.53%
Operating Expenses	$17.33M	$15.93M	$14.85M
YoY Change	16.66%	31.66%	29.03%
Operating Profit	-$15.53M	-$12.93M	-$11.00M
YoY Change	41.09%	65.68%	54.81%
Interest Expense	$301.0K	-$6.910M	$34.00K
YoY Change	785.29%	-483.89%	-68.22%
% of Operating Profit
Other Income/Expense, Net	-$2.482M	-$240.0K	$3.459M
YoY Change	-171.75%	-112.01%	689.73%
Pretax Income	-$18.01M	-$20.08M	-$7.545M
YoY Change	138.66%	245.79%	13.12%
Income Tax	-$2.035M	$110.0K	$44.00K
% Of Pretax Income
Net Earnings	-$15.97M	-$20.18M	-$7.589M
YoY Change	110.46%	244.4%	12.86%
Net Earnings / Revenue	-180.88%	-210.51%	-88.23%
Basic Earnings Per Share	-$0.17	-$0.26	-$0.10
Diluted Earnings Per Share	-$0.17	-$0.26	-$0.16
COMMON SHARES
Basic Shares Outstanding	95.73M shares	78.27M shares	72.90M shares
Diluted Shares Outstanding	95.73M shares		74.52M shares

Balance Sheet

Concept	2015 Q2	2014 Q4	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$110.9M	$51.29M	$49.70M
YoY Change	123.16%	-11.1%	-14.6%
Cash & Equivalents	$35.06M	$22.78M	$28.56M
Short-Term Investments	$75.85M	$28.51M	$21.10M
Other Short-Term Assets	$1.411M	$1.932M	$1.416M
YoY Change	-0.35%	337.1%	608.0%
Inventory	$13.68M	$14.96M	$13.38M
Prepaid Expenses	$1.009M	$1.210M	$1.353M
Receivables	$5.425M	$5.493M	$4.478M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$144.5M	$74.89M	$70.32M
YoY Change	105.45%	-4.18%	-9.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.816M	$3.781M	$3.615M
YoY Change	5.56%	72.73%	120.29%
Goodwill	$1.316M	$1.316M	$1.316M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$1.041M	$1.142M	$1.243M
YoY Change	-16.25%	-15.03%	-13.98%
Long-Term Investments
YoY Change
Other Assets	$140.0K	$144.0K	$51.00K
YoY Change	174.51%	105.71%	-29.17%
Total Long-Term Assets	$6.935M	$6.891M	$6.532M
YoY Change	6.17%	31.83%	36.71%
TOTAL ASSETS
Total Short-Term Assets	$144.5M	$74.89M	$70.32M
Total Long-Term Assets	$6.935M	$6.891M	$6.532M
Total Assets	$151.4M	$81.78M	$76.85M
YoY Change	97.01%	-1.92%	-6.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.765M	$9.882M	$3.169M
YoY Change	81.92%	74.16%	-37.06%
Accrued Expenses	$6.914M	$8.444M	$10.62M
YoY Change	-34.89%	-13.95%	21.39%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.500M	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$22.22M	$29.19M	$21.71M
YoY Change	2.38%	-25.97%	-17.72%
LONG-TERM LIABILITIES
Long-Term Debt	$17.40M	$9.900M	$9.800M
YoY Change	77.55%
Other Long-Term Liabilities	$1.160M	$1.081M	$987.0K
YoY Change	17.53%	0.75%	-13.8%
Total Long-Term Liabilities	$1.160M	$1.081M	$987.0K
YoY Change	17.53%	0.75%	-13.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.22M	$29.19M	$21.71M
Total Long-Term Liabilities	$1.160M	$1.081M	$987.0K
Total Liabilities	$40.88M	$40.26M	$32.64M
YoY Change	25.22%	-0.82%	18.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$567.4M	-$541.9M	-$511.0M
YoY Change	11.03%	7.7%	7.17%
Common Stock	$670.4M	$583.5M	$74.00K
YoY Change	905878.38%	6.87%	5.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$110.5M	$41.52M	$44.21M
YoY Change
Total Liabilities & Shareholders Equity	$151.4M	$81.78M	$76.85M
YoY Change	97.01%	-1.92%	-6.9%

Cashflow Statement

Concept	2015 Q2	2014 Q4	2014 Q2
OPERATING ACTIVITIES
Net Income	-$15.97M	-$20.18M	-$7.589M
YoY Change	110.46%	244.4%	12.86%
Depreciation, Depletion And Amortization	$400.0K	$430.0K	$290.0K
YoY Change	37.93%	26.47%	163.64%
Cash From Operating Activities	-$14.73M	-$8.630M	-$9.610M
YoY Change	53.28%	32.16%	68.89%
INVESTING ACTIVITIES
Capital Expenditures	-$270.0K	-$80.00K	-$590.0K
YoY Change	-54.24%	-63.64%	293.33%
Acquisitions
YoY Change
Other Investing Activities	$17.89M	-$3.790M	$2.970M
YoY Change	502.36%	-683.08%	-29800.0%
Cash From Investing Activities	$17.61M	-$3.870M	$2.380M
YoY Change	639.92%	-1000.0%	-1587.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	14.24M	12.93M	11.81M
YoY Change	20.58%	15.14%	-331.12%
NET CHANGE
Cash From Operating Activities	-14.73M	-8.630M	-9.610M
Cash From Investing Activities	17.61M	-3.870M	2.380M
Cash From Financing Activities	14.24M	12.93M	11.81M
Net Change In Cash	17.12M	430.0K	4.580M
YoY Change	273.8%	-91.62%	-141.79%
FREE CASH FLOW
Cash From Operating Activities	-$14.73M	-$8.630M	-$9.610M
Capital Expenditures	-$270.0K	-$80.00K	-$590.0K
Free Cash Flow	-$14.46M	-$8.550M	-$9.020M
YoY Change	60.31%	35.5%	62.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Share Price SharePrice	5.50
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	96776273	shares
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28562000
CY2014Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1200000
CY2015Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	21800000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14136000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.24
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2467000
CY2015Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3978000
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	22224000
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3495000
CY2015Q2	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	3978000
CY2015Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	122000
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6914000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0
CY2015Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	400000
CY2015Q2	us-gaap	Liabilities Liabilities	40877000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5226000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3164000
CY2015Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	976000
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	97000
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	670327000
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	12041000
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1160000
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	577000
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7481000
CY2015Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	2523000
CY2015Q2	us-gaap	Long Term Debt LongTermDebt	20000000
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2384000
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	613000
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-567376000
CY2015Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	36000
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	110529000
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	151406000
CY2015Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	17371000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000
CY2015Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0
CY2015Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4096000
CY2015Q2	us-gaap	Assets Assets	151406000
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	8000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	100000
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5425000
CY2015Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	94441000
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	140000
CY2015Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	94441000
CY2015Q2	us-gaap	Inventory Net InventoryNet	13681000
CY2015Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	75854000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	200000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Interest In Year Four LongTermDebtMaturitiesRepaymentsOfInterestInYearFour	450000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6007000
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5603000
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3978000
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5765000
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	106474000
CY2015Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	622000
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1041000
CY2015Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9585000
CY2015Q2	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	800000
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3816000
CY2015Q2	us-gaap	Assets Current AssetsCurrent	144471000
CY2015Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1411000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	200000
CY2015Q2	us-gaap	Goodwill Goodwill	1316000
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	94441000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	200000
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	94442000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2015Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1009000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1041000
CY2015Q2	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	12032000
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35059000
CY2015Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	94442000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Principal And Interest LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest	24640000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Interest LongTermDebtMaturitiesRepaymentsOfInterest	4640000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Interest In Year Five LongTermDebtMaturitiesRepaymentsOfInterestInYearFive	1465000
CY2015Q2	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	45000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo	6457000
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000
CY2014Q4	us-gaap	Liabilities Liabilities	40255000
CY2014Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	875000
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	80000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Interest Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfInterestRemainderOfFiscalYear	640000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Interest In Year Three LongTermDebtMaturitiesRepaymentsOfInterestInYearThree	854000
CY2015Q2	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	61000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree	6457000
CY2015Q2	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	17432000
CY2015Q2	cers	Options And Other Stock Based Awards OptionsAndOtherStockBasedAwards	14100000	shares
CY2015Q2	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	2	Customer
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFour	6457000
CY2015Q2	cers	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	100000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Interest In Year Two LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo	1231000
CY2015Q2	cers	Accrued Inventory AccruedInventory	42000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Principal And Interest Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestRemainderOfFiscalYear	640000
CY2015Q2	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFive	4629000
CY2015Q2	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	2568000
CY2015Q2	cers	Accrued Customer Costs And Deposits Current AccruedCustomerCostsAndDepositsCurrent	344000
CY2015Q2	cers	Accrued Leasehold Improvements Current And Other Leasehold Improvements Noncurrent AccruedLeaseholdImprovementsCurrentAndOtherLeaseholdImprovementsNoncurrent	600000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29485000
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11323000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.13
CY2014Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10485000
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29187000
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3951000
CY2014Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	10485000
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	115000
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8444000
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	583416000
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1081000
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	376000
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-31000
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2123000
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	851000
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-541944000
CY2014Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	264000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	41521000
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81776000
CY2014Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	9872000
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	10485000
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9882000
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	33426000
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	508000
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1142000
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12734000
CY2014Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	1300000
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3781000
CY2014Q4	us-gaap	Assets Current AssetsCurrent	74885000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	5705000
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1932000
CY2014Q4	us-gaap	Goodwill Goodwill	1316000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	27752000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	27727000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1210000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1142000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22781000
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	33426000
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2222000
CY2014Q4	us-gaap	Assets Assets	81776000
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	31000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5699000
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5493000
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	33457000
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	144000
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	33457000
CY2014Q4	us-gaap	Inventory Net InventoryNet	14956000
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	28513000
CY2014Q4	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	128000
CY2014Q4	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	10000000
CY2014Q4	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	1	Customer
CY2014Q4	cers	Accrued Inventory AccruedInventory	870000
CY2014Q4	cers	Accrued Customer Costs And Deposits Current AccruedCustomerCostsAndDepositsCurrent	385000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2432000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11587000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72495000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-19436000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74927000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	450000
	us-gaap	Payments For Royalties PaymentsForRoyalties	1300000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7815000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1429000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7732000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	54000
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	3492000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20223000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1411000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20855000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1647000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3419000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	16467000
	us-gaap	Dilutive Securities DilutiveSecurities	-13041000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12491000
	us-gaap	Net Income Loss NetIncomeLoss	-7814000
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	3800000
	us-gaap	Gross Profit GrossProfit	7558000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
	us-gaap	Interest Expense InterestExpense	84000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3847000
	us-gaap	Operating Expenses OperatingExpenses	27781000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	13135000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	615000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10299000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9848000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	9364000
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2859000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	85000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-12525000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-923000
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2286000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2625000
	us-gaap	Share Based Compensation ShareBasedCompensation	2286000
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18316000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	743000
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	5378000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	8909000
	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	12500000
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	9500000
	dei	Document Type DocumentType	10-Q
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3000	shares
	dei	Trading Symbol TradingSymbol	CERS
	dei	Entity Central Index Key EntityCentralIndexKey	0001020214
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1106000	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Reclassifications</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain reclassifications have been made to prior period reported amounts to conform to the current period presentations. Previously the Company had presented the amortization of premium and accretion of any discount resulting from the purchase of fixed income securities as a component of “Interest expense” on the unaudited condensed consolidated statements of operations. For the three and six months ended June 30, 2014, the Company has reclassified approximately $0.1 million and $0.3 million, respectively, of the amortization of premium resulting from the purchase of fixed income securities as a component of “Other income, net” on the unaudited condensed consolidated statements of operations. This reclassification had no impact on net loss, total assets or total stockholders’ equity.</p> </div>
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5793000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	74000	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and non-equity short-term investments are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments are investment grade and carry high credit quality ratings, which is in accordance with its investment policy. At June 30, 2015, the fair value of the Company’s marketable equity securities of Aduro is subject to the underlying volatility of Aduro’s stock price. At June 30, 2015, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">  </p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses. At June 30, 2015 and December 31, 2014, the Company had not recorded any reserves for potentially uncollectible accounts.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company had two customers and one customer that accounted for more than 10% of the Company’s outstanding trade receivables at each of June 30, 2015 and December 31, 2014, respectively. These customers cumulatively represented approximately 43% and 36% of the Company’s outstanding trade receivables at June 30, 2015, and December 31, 2014, respectively. To date, the Company has not experienced collection difficulties from these customers.</p> </div>
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.54
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94576000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.51
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-30484000
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.90
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	261000	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>Guarantee and Indemnification Arrangements</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims are probable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims and does not carry a warranty claim liability at June 30, 2015 and December 31, 2014.</p> </div>
	dei	Entity Registrant Name EntityRegistrantName	CERUS CORP
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>Use of Estimates</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	256000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3589000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	2918000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7000
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.87
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95682000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3151000	shares
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-739000
	us-gaap	Payments For Royalties PaymentsForRoyalties	1300000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-614000
	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17920000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	325000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-27448000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29000
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	69983000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-29896000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1112000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-29021000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-69000
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	114000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	56000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	16522000
	us-gaap	Dilutive Securities DilutiveSecurities	-3589000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2448000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3589000
	us-gaap	Net Income Loss NetIncomeLoss	-25432000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-139000
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	900000
	us-gaap	Gross Profit GrossProfit	4780000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7512000
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
	us-gaap	Interest Expense InterestExpense	556000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75324000
	us-gaap	Operating Expenses OperatingExpenses	34676000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	90740000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	4552000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	835000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2016000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	22444000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10000000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	10794000
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5472000
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74517000	shares
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	12278000
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3179000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4176000
	us-gaap	Share Based Compensation ShareBasedCompensation	3179000
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23781000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1538000
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-47978000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	11742000
	cers	Safety Product Warranty Period SafetyProductWarrantyPeriod	P1Y
	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	3600000
	cers	Work In Process Inventory Life Period WorkInProcessInventoryLifePeriod	P1Y
	cers	Minimum Term Of Non Cancelable Operating Leases MinimumTermOfNonCancelableOperatingLeases	P1Y
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	9400000
	cers	Prior Written Notice Period For Termination Of Agreement PriorWrittenNoticePeriodForTerminationOfAgreement	P24M
	cers	Expiration Of Non Cancelable Operating Leases Maximum Year ExpirationOfNonCancelableOperatingLeasesMaximumYear	2019
CY2014Q2	us-gaap	Payments For Royalties PaymentsForRoyalties	600000
	cers	Inventory Life Finished Goods Period InventoryLifeFinishedGoodsPeriod	P2Y
	cers	Excess Tax Benefit From Unrealized Gain On Available For Sale Securities Operating Activities ExcessTaxBenefitFromUnrealizedGainOnAvailableForSaleSecuritiesOperatingActivities	2085000
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14636363	shares
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5100000
CY2015Q1	cers	Estimated Net Proceeds From Public Offering EstimatedNetProceedsFromPublicOffering	75400000
CY2010	cers	Proceeds From Landlord Financing Leasehold Improvement ProceedsFromLandlordFinancingLeaseholdImprovement	1100000
CY2014Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1618000	shares
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12160000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72899000	shares
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000
CY2014Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2014Q2	us-gaap	Interest Expense InterestExpense	34000
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	14853000
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51000
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44000
CY2014Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4722000
CY2014Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3491000
CY2014Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1341000
CY2014Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10080000
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95728000	shares
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2014Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2014Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4752000
CY2014Q2	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	-3500000
CY2014Q2	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4900000
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9895000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95728000	shares
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2015Q2	us-gaap	Payments For Royalties PaymentsForRoyalties	500000
CY2015Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	499000
CY2015Q2	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8479000
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18007000
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27000
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-15525000
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15972000
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-25000
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7590000
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7545000
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27000
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11004000
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11596000
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8601000
CY2014Q2	us-gaap	Dilutive Securities DilutiveSecurities	-4007000
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3459000
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-7589000
CY2014Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	1100000
CY2014Q2	us-gaap	Gross Profit GrossProfit	3849000
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8830000
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2482000
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-15972000
CY2015Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	500000
CY2015Q2	us-gaap	Gross Profit GrossProfit	1802000
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7493000
CY2015Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2015Q2	us-gaap	Interest Expense InterestExpense	301000
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	17327000
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51000
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	4552000
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2035000
CY2015Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	5213000
CY2015Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2707000
CY2015Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1704000
CY2015Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12063000
CY2015Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2015Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	7028000
CY2015Q2	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	-2700000
CY2015Q2	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4700000

Files In Submission

Name	View Source	Status
0001193125-15-283091-index-headers.html	Edgar Link	pending
0001193125-15-283091-index.html	Edgar Link	pending
0001193125-15-283091.txt	Edgar Link	pending
0001193125-15-283091-xbrl.zip	Edgar Link	pending
cers-20150630.xml	Edgar Link	completed
cers-20150630.xsd	Edgar Link	pending
cers-20150630_cal.xml	Edgar Link	unprocessable
cers-20150630_def.xml	Edgar Link	unprocessable
cers-20150630_lab.xml	Edgar Link	unprocessable
cers-20150630_pre.xml	Edgar Link	unprocessable
d945175d10q.htm	Edgar Link	pending
d945175dex101.htm	Edgar Link	pending
d945175dex102.htm	Edgar Link	pending
d945175dex311.htm	Edgar Link	pending
d945175dex312.htm	Edgar Link	pending
d945175dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CERS
CERUS CORP Stock $cers

2015 Q2 Form 10-Q Financial Statement

#000119312515283091 Filed on August 07, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS CERUS CORP Stock $cers

2015 Q2 Form 10-Q Financial Statement

#000119312515283091 Filed on August 07, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS
CERUS CORP Stock $cers